A health care provider outlines treatment objectives and supportive interventions for managing Friedreich ataxia, addressing associated comorbidities and symptoms in clinical settings. A key opinion ...
When Design Therapeutics DSGN+0.82%, Inc. (DSGN) reported four-week results for DT-216P2 in May, biotech 865238-0.87% ...
In the crowded history of early twentieth-century neurology, the names that survive in eponyms are usually those of men. Yet one of the most elegant clinical descriptions of a hereditary neurological ...
Charlotte Casey, aged 25, and her 28 year-old sister Olivia Dews suffer from a rare genetic condition called Friedreich’s ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for ...
Higher levels of high-sensitivity cardiac troponin T were independently associated with lower myocardial capillary density in ...
In this week’s Street Stories Unpaved, hosts Mike Montecalvo and Johnny Villella sit down with Charlie and his twin sister ...
Important research news last week included US biotech Celldex Therapeutics releasing positive Phase III results for ...
Hundreds of people walked and ran in the 17th Annual FARA 5K Race for Matt and Grace on Saturday morning. Due to the rain, ...
Biotech’s headline index is hiding a bloodbath in long-short funds, but the real story this week is in the data. Yaron Werber, speaking on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results